We are a start-up biotechnology company that aims to create innovative first-in-class biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illnesses.
We are a start-up biotechnology company that aims to create innovative first-in-class biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illnesses.